Comparison of survival among multimodality treatment regimens in malignant pleural mesothelioma patients in an integrated health system

被引：0
|
作者：
Banks, K. [1 ]
Ossowski, S. [2 ]
Hung, Y-Y. [3 ]
Hsu, D. S. [1 ]
Ashiku, S. K. [4 ]
Patel, A. R. [4 ]
Velotta, J. B. [4 ]
Suga, J. M. [5 ]
机构：
[1] Univ Calif San Francisco East Bay, Surg, Oakland, CA USA
[2] Kaiser San Francisco Med Ctr, Hematol Oncol, San Francisco, CA USA
[3] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[4] Kaiser Permanente Oakland Med Ctr, Thorac Surg, Oakland, CA USA
[5] Kaiser Permanente Vallejo Med Ctr, Oncol, Vallejo, CA USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
124P
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [1] Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
    Banks, Kian C.
    Ossowski, Stephanie
    Hung, Yun-Yi
    Hsu, Diana S.
    Ashiku, Simon K.
    Patel, Ashish R.
    Velotta, Jeffrey B.
    Suga, J. Marie
    [J]. CLINICAL LUNG CANCER, 2022, 23 (08) : 694 - 701
  • [2] Effects of treatment regimens on survival in patients with malignant pleural mesothelioma
    Abakay, A.
    Abakay, O.
    Tanrikulu, A. C.
    Sezgi, C.
    Sen, H.
    Kaya, H.
    Kucukoner, M.
    Kaplan, M. A.
    Celik, Y.
    Senyigit, A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (01) : 19 - 24
  • [3] Comment on "Effects of treatment regimens on survival in patients with malignant pleural mesothelioma"
    Fiorica, F.
    Fisichella, R.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (03) : 424 - 425
  • [4] MULTIMODALITY TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA
    Kurchenkov, Aleksey
    Zharkov, Vladimir
    Kurchin, Vyacheslav
    Stefanovich, Zhanna
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1352 - S1353
  • [5] Survival patterns in patients with malignant pleural mesothelioma using multimodality therapy
    Hassan, M.
    Uthman, I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S129 - S130
  • [6] Multimodality treatment of diffuse malignant pleural mesothelioma
    Zellos, LS
    Sugarbaker, DJ
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 41 - 50
  • [7] Role of Surgery in the Multimodality Treatment of Malignant Pleural Mesothelioma
    Na, B.
    Kim, J.
    Park, S.
    Hyun, K.
    Park, I. K.
    Kang, C. H.
    Kim, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2309 - S2309
  • [8] Improving Outcomes in Malignant Pleural Mesothelioma in an Integrated Health System
    Ossowski, S.
    Hung, Y.
    Suga, M.
    Velotta, J. B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1064 - S1065
  • [9] A multimodality treatment for malignant pleural mesothelioma patients with or without lymph node metastases
    Cengel, K. A.
    Fernandes, A.
    Mick, R.
    Smith, B.
    Culligan, M.
    Stevenson, J.
    Sterman, E. I.
    Glatstein, E.
    Hahn, S. M.
    Friedberg, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma
    Baez-Saldana, R.
    Marmolejo-Torres, M. T.
    Iniguez-Garcia, M.
    Berrios Mejia, J. A.
    Rumbo-Nava, U.
    Arrieta-Rodriguez, O.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345